Diabetes Education 공개
[search 0]
Download the App!
show episodes
 
Artwork

1
Know Diabetes by Heart™ Professional Education Podcast Series

American Heart Association and American Diabetes Association

Unsubscribe
Unsubscribe
매달
 
The American Heart Association and the American Diabetes Association are excited to announce a new podcast series for healthcare professionals. Know Diabetes by Heart™ Professional Education Podcast Series focuses on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D). The series will consist of relevant cutting-edge topics such as up-to-date standards of care, guidelines and their implications for T2D and CVD, and approaches to shared decision making—among others. The Am ...
  continue reading
 
Loading …
show series
 
Listen to Katherine R. Tuttle, MD, FASN, FACP, FNKF, Anthony Good, DNP, MBA, FNP-BC, GNP-BC, and Joshua J. Neumiller, PharmD, CDCES, FASCP, FADCES discuss the prevalence of heart failure, chronic kidney disease, type 2 diabetes, and the impact these conditions have on patient outcomes. Management options to mitigate these risks, current guidelines …
  continue reading
 
Listen to Rodica Busui (Pop-Busui), MD, PhD, Neha J. Pagidipati, MD, MPH, and Jennifer B. Green, MD discuss ASCVD (atherosclerotic cardiovascular disease) progression in patients with type 2 diabetes, strategies to assess its risk, and the COORDINATE study.
  continue reading
 
Listen to Michael J. Blaha, MD, MPH and Richard E. Pratley, MD discuss the link between type 2 diabetes and chronic kidney disease (CKD) as well as taking a multidisciplinary approach to managing people with type 2 diabetes at risk for chronic kidney disease progression.저자 American Heart Association
  continue reading
 
Listen to Traci Thompson, MD, MBA, CPE, Latha Palaniappan, MD, MS, and Alka Kanaya, MD discuss racial and ethnic considerations when screening and managing patients with type 2 diabetes (T2D) and cardiovascular disease (CVD), as well as related health care disparities and barriers in managing and treating T2D and CVD.…
  continue reading
 
This podcast highlights the new science presented at the American Heart Association’s (AHA’s) Scientific Sessions in 2022. Jane Reusch, MD, Nathan Wong, PhD, MPH, and Chiadi Ndumele, MD, PhD, MHS discuss clinical highlights related to CVD risk management in patients with diabetes, including renal disease, and how to incorporate these findings into …
  continue reading
 
Help patients with diabetes manage their risk for heart disease and stroke. Donald Lloyd-Jones, MD, ScM, FAHA, FACC and Jane EB Reusch, MD, FAHA discuss the recent release of AHA’s Life’s Essential 8 which was expanded from Life’s Simple 7 to include healthy sleep for optimal cardiovascular health as well as other lifestyle factors included in Life…
  continue reading
 
Diabetes is more than a blood sugar problem. Help your patients with type 2 diabetes understand their risk of cardiovascular disease and the importance of blood pressure, lipid, and glucose control in managing risk. Listen to Nathan Wong, PhD, MPH and Colette Knight, MD discuss ways for patients to know and understand their numbers in LDL cholester…
  continue reading
 
Listen to Philip P. Goodney, MD, MS, Foluso A. Fakorede, MD and Peter A. Schneider, MD discuss the differences in preventive measures offered to patients with diabetes and peripheral artery disease (PAD) as well as better delivery of preventive measures to high-risk patients and high-risk regions in the United States.…
  continue reading
 
Listen to Dr. Jennifer Green and Dr. Neha Pagidipati discuss the utilization of SGLT2i and GLP-1RA in the hospital setting in patients with indications for such therapy, as described in the 2021 ADA Standards of Medical Care and current AHA guidelines, including the recent ASA/AHA Recurrent Stroke prevention guidelines.…
  continue reading
 
Listen to George L. Bakris, MD, FAHA, FASN, Cecilia C. Low Wang, MD, FACP and Neda Rasouli, MD educate clinicians on the updates made in the 2021 ADA Standards of Care related to metformin use and considerations for when the guideline recommends considering use of SGLT-2 Inhibitors and GLP-1 receptor agonists independent of A1C or metformin use.…
  continue reading
 
డయాబెటిస్ గురించి తెలుగు లో ఆరోగ్య విజ్ఞానం.నిర్వచనాలు , టైప్ 1,234, లక్షణాలు, వ్యాధి నిర్థారణ పరీక్షలు
  continue reading
 
మధుమేహం ప్రపంచం లో ఎలా వ్యాపిస్తోంది: కారణాలు: ఎందుకు నివారణ చికిత్స తీసుకోవాలి? The epidemiology of Diabetes worldwide,and reasons for the high increase.Why we should we prevent and treat it.
  continue reading
 
తెలుగు లో మధుమేహం అంటే డయాబెటిస్ వ్యాధి గురించి, ఆహారనియమాలు , మందులు, చికిత్స గురించి, ఆరోగ్య విజ్ఞానం.ఫిజీషియన్,డయబిటాలజిస్ట్ డాక్టర్ మథు చిత్తర్వు MD FICP వివరణలు.
  continue reading
 
Listen to Dr. Boris Draznin, an endocrinologist and specialist in diabetes and internal medicine, and Dr. Pam Kushner, a specialist in family medicine discuss how the new American Diabetes Association’s 2021 Standards of Care have changed and implications for practice.
  continue reading
 
Patients with T2D and CKD have a very high risk of CV events. Listen as Dr. Jorge Plutzky and Dr. Neha Pagidipati discuss new therapies to manage cardiovascular and renal risk in patients with T2D. Their discussion is based on new science presented during AHA Scientific Sessions 2020.
  continue reading
 
Listen as Dr. Eduardo Sanchez from the American Heart Association and Dr. Robert Gabbay from the American Diabetes Association discuss social determinants of health and disparities in health and health care in individuals with type 2 diabetes at risk for cardiovascular disease and COVID-19 and what can be done to improve their outcomes.…
  continue reading
 
Listen to leading experts discuss the new Scientific Statement from the American Heart Association, “Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease,” where two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) …
  continue reading
 
Listen to members of the writing group for the new AHA statement on the clinical management of stable coronary artery disease in patients with T2D. Dr. Suzanne Arnold, Chair, and fellow writing group members, Dr. Prakash Deedwania and Dr. Mikhail Kosiborod will review highlights from the statement, including recent clinical trials which uncovered s…
  continue reading
 
People with type 2 diabetes and chronic kidney disease are at three times higher risk of dying from a cardiovascular event. According to the National Kidney Foundation, the two main causes of chronic kidney disease are diabetes and high blood pressure. These two conditions were the primary diagnosis in 75% of kidney failure cases between 2015-2017.…
  continue reading
 
Listen to Dr. Nancy Albert, a clinical nurse specialist and lead researcher in heart failure and Dr. Mikhail Kosiborod, a cardiologist and expert in the fields of diabetes, cardiovascular diseases, cardiometabolic and cardiorenal syndromes, and quality care and outcomes discuss heart failure management in patients with type 2 diabetes and cardiovas…
  continue reading
 
Studies on COVID-19 are revealing that patients diagnosed with COVID-19 and who have type 2 diabetes and history of cardiovascular disease are showing increased complications. Listen to Dr. Anne Peters, an endocrinology, diabetes and metabolism specialist and Dr. Diana Issacs, an endocrine clinical pharmacy specialist discuss tackling COVID-19 in t…
  continue reading
 
Goal setting and discussing lifestyle management with your patients is critical in managing the link between diabetes and heart disease. Listen to Dr. Nathanial Clark, an endocrinologist, and Melissa Magwire, a nurse and CDE (Certified Diabetes Educator) discuss how to initiate the conversation and set your patient up for success.…
  continue reading
 
In a recent survey of people age 45 and older with type 2 diabetes, conducted online by The Harris Poll, only half recognize their cardiovascular risk or have discussed their risk of heart attacks or strokes with their health care providers. Listen to cardiologist, Dr. Tracy Wang and endocrinologist, Dr. Robert Eckel discuss how a cardiologist can …
  continue reading
 
The management of type 2 diabetes to prevent cardiovascular disease has been focused on glycemic control and the use of drugs based on their ability to lower levels of glycemia. Listen to Dr. Robert Eckel and Dr. Chris Cannon discuss the use of anti-hyperglycemic agents with CVD benefits.
  continue reading
 
Diabetes education has positive effects not only on psychosocial and behavioral aspects of diabetes care, but also known to be a cost-effective treatment by reducing hospital readmissions and lowered risk for complications. Yet, many patients often do not receive DSMES (Diabetes Self-Management Education and Support) referrals. Listen to Nancy D’Ho…
  continue reading
 
Identifying and implementing optimal treatment strategies for patients living with diabetes and heart failure is critical to improving outcomes for this population. Shannon Dunlay, MD, MS discusses managing patients with diabetes who are at risk for heart failure or those that have heart failure. This podcast is based on the new scientific statemen…
  continue reading
 
Shared decision-making is an effective approach to ensure patient and family involvement in decision-making and tailoring of treatment plans to meet goals. Jay Shubrook, DO, Robert Eckel, MD, and Patricia Montesinos, CRNP, CDE discuss how to interview and bring their patients to a collaborative discussion and joint treatment plan.…
  continue reading
 
For people with diabetes, blood glucose isn’t the only important factor to track. New guidelines suggest the more than 110 million U.S. adults with diabetes or prediabetes should also manage their cholesterol as well as their blood glucose. Drs. Ronald Goldberg and Robert Eckel discuss the new American Heart Association’s 2018 Cholesterol Guideline…
  continue reading
 
Loading …

빠른 참조 가이드